Key facts
- PurposeMed’s last known valuation is $104.8M (Mar 2025).
- It has raised $19.7M; the latest was Later Stage VC ($11.9M) in Mar 2025.
- Notable investors include BDC Capital, Panache Ventures, Azure Capital Partners, C100, Prairies Economic Development Canada — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for PurposeMed
- ·The full record, as it builds
Funding rounds
No funding rounds for PurposeMed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PurposeMed
Operator of growth telehealth brands designed to improve access to complex care for underserved communities worldwide. The company's system provides affirming and high-quality care, without judgment and without waiting rooms, enabling the patient to get connected with clinicians feasibly and receive compassionate healthcare from the comfort of their home.
- Sector
- Healthcare
- HQ
- Calgary, Canada
- Founded
- 2019
- Employees
- 200
- Website
- purposemed.com/
- Ownership
- Privately Held (backing)
PurposeMed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PurposeMed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PurposeMed in its N-PORT filings yet. We sweep new filings monthly.